Clinical trials: Compulsive Behavior

Autism Spectrum Disorder

FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders

• Completed
• Age: 10 to 55 years
• Phase 4
• Results posted

This is an 8 week research study of aripiprazole (abilify) which is used to reduce irritable behaviors in autism spectrum disorders. All participants will receive active study medication.

Trial name

AripfMRI (NCT01028820)

Testing

Aripiprazole

Where

2 sites in United States

Volunteers

13 people

Sponsor

University of North Carolina, Chapel Hill